Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal
Hemodiafiltration, Chronic Kidney Disease Requiring Chronic Dialysis
About this trial
This is an interventional treatment trial for Hemodiafiltration
Eligibility Criteria
Inclusion Criteria:
- Age greater or equal to 18 years.
- Patients that receive OL-HDF three times per week.
- Patients with no residual uresis.
- Hemoglobin greater that 7 g/L.
- Patients that can exercise during treatment.
- Patients must sign informed consent.
Exclusion Criteria:
- Age less tan 18.
- Presence of residual uresis.
- Hb less that 7 g/L.
- Patients incapable of exercising during dialysis.
Sites / Locations
- Instituto Nacional de Cardiologia Ignacio Chávez
- Instituto Nacional de Cardiología Ignacio Chávez
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
High Flux Hemodialysis
Extended Hemodialysis
On Line Hemodiafiltration
On Line Hemodiafiltration with an MCO membrane
High Flux Hemodialysis with an FxCordiax 120 membrane, with Qb of 350, 4 hours of treatment.
Extended Hemodialysis with a Theranova 400 membrane, with Qb of 350, 4 hours of treatment.
On Line Hemodiafiltration with an FxCordiax 120 membrane, with Qb of 350, 4 hours of treatment, and post filter substitution rate of 20-21 liters.
On Line Hemodiafiltration with a Theranova 400 membrane, with Qb of 350, 4 hours of treatment, and post filter substitution rate of 20-21 liters.